A synthetic peptide for use as a blocking control in assays to test for specificity of GABRA5 antibody, Alternative Names: GABRA5 control peptide, GABRA5 antibody Blocking Peptide, Anti-GABRA5 Blocking Peptide, Gamma-Aminobutyric Acid Blocking Peptide, Gaba A Receptor Alpha 5 Blocking Peptide, MGC138184 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
GABRA5
(gamma-aminobutyric Acid (GABA) A Receptor, alpha 5 (GABRA5))
Synonyme
GABRA5 Peptide, si:dkey-93p24.1 Peptide, A230018I05Rik Peptide, gamma-aminobutyric acid type A receptor alpha5 subunit Peptide, gamma-aminobutyric acid (GABA) A receptor, alpha 5 Peptide, gamma-aminobutyric acid type A receptor alpha 5 subunit Peptide, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 Peptide, gamma-aminobutyric acid receptor subunit alpha-5 Peptide, GABRA5 Peptide, gabra5 Peptide, Gabra5 Peptide, LOC100653497 Peptide
Hintergrund
GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified.